A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 18
Abstract
Purpose: Chemotherapy-induced peripheral neuropathy is a complex side effect with few available treatment options. The aim of the study was to test the effectiveness of an 8-week course of acupuncture in the management of chemotherapy-induced peripheral neuropathy in cancer patients who were receiving or had received neurotoxic chemotherapy. Methods: Randomized assessor-blinded controlled trial with 2 arms; one arm received acupuncture twice weekly for 8 weeks, while the other arm was a wait-list control group receiving only standard care. Primary outcome was pain intensity and interference over the past week using the Brief Pain Inventory at the end of the intervention. Secondary outcomes included clinical assessment (CTCAE [Common Toxicity Criteria for Adverse Events] grading and Total Neuropathy Score–Clinical Version) and nerve conduction studies; and patient-reported outcome measures (Functional Assessment of Cancer Therapy–Gynecologic Oncology Group–Neurotoxicity Quality of Life scale and Symptom Distress Scale) assessed at baseline, end of treatment (8 weeks), week 14, and week 20 from the beginning of treatment. Results: Eighty-seven patients were randomized to the experimental arm (n = 44) and to the standard care wait-list control arm (n = 43). Significant changes at 8 weeks were detected in relation to primary outcome (pain), the clinical neurological assessment, quality of life domains, and symptom distress (all P < .05). Improvements in pain interference, neurotoxicity-related symptoms, and functional aspects of quality of life were sustained in the 14-week assessment (P < .05), as were physical and functional well-being at the 20-week assessment (P < .05). Conclusions: Acupuncture is an effective intervention for treating chemotherapy-induced peripheral neuropathy and improving patients’ quality of life and experience with neurotoxicity-related symptoms with longer term effects evident.Keywords
Funding Information
- Health and Medical Research Fund (12131801)
This publication has 30 references indexed in Scilit:
- Reply to A. Azad et alJournal of Clinical Oncology, 2013
- A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupunctureAnnals of Oncology, 2013
- Minimal clinically important differences in the brief pain inventory in patients with bone metastasesSupportive Care in Cancer, 2013
- Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trialSupportive Care in Cancer, 2012
- Chemotherapy‐induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scaleJournal of the Peripheral Nervous System, 2011
- Evaluation of Acupuncture in the Management of Chemotherapy-Induced Peripheral NeuropathyAcupuncture in Medicine, 2011
- Chemotherapy-Induced Peripheral NeuropathyOncology Nursing Forum, 2005
- Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapiesSupportive Care in Cancer, 2004
- Analgesic Effect of Auricular Acupuncture for Cancer Pain: A Randomized, Blinded, Controlled TrialJournal of Clinical Oncology, 2003
- Grading of chemotherapy-induced peripheral neuropathyAnnals of Oncology, 2000